Thats fantastic news,   maybe we can the ball rolling a deal now ...!!      Still wondering if the DSMB would allow a trial to continue over 18 months if effacy was zero,   IMO that would not be ethical to continue a trial that long without any benefit,    At this point with over 1600 patients dosed, with an event rate of around 12%  we should have close to 200 events at this point,  we should be close to the completion of the FA within a month or so ,  maybe the longer it takes the better the result....  maybe